NCT02474888View on ClinicalTrials.gov

Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis

TerminatedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

September 15, 2015

Primary Completion Date

June 12, 2020

Study Completion Date

June 12, 2020

Conditions
Granulomatosis, Wegener'sMicroscopic Polyangiitis
Interventions
OTHER

blood specimen

blood specimen for serum rituximab level and serum anti-rituximab level at M1 and M3 after stop of induction rituximab treatment

Trial Locations (4)

42055

CHU Saint-Etienne, Saint-Etienne

69003

Hôpital Edouard Herriot, Lyon

69317

Hôpital de la Croix Rousse, Lyon

69495

CH Lyon Sud, Pierre-Bénite

Sponsors

Collaborators (1)

Theradiag
All Listed Sponsors
collaborator

Theradiag

OTHER

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER